American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention

Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

Given the availability of therapies to prevent SCD due to otherwise fatal ventricular tachyarrhythmias, it is important to differentiate noninvasive risk stratification techniques that enhance the ability to identify SCD from total mortality. The relative ability for each of the described techniques varies, and the optimal way to combine and use these techniques in clinical practice remains unclear. Low LVEF, which is the most widely used test on which ICD intervention is recommended, does not have a particularly high discriminatory ability to identify SCD rather than non-SCD mortality. Although data exist supporting the concept that noninvasive risk stratification techniques may be useful to identify patients with low LVEF who are at low risk for SCD, this requires further testing. There are also data to support the concept that noninvasive risk stratification techniques may be useful to identify patients who do not have low LVEF who nevertheless are at substantial risk for SCD. Because most SCD occurs in this latter group, substantial effort is justified in evaluating, testing, and ultimately implementing risk stratification strategies in this group.

Original languageEnglish
Pages (from-to)1497-1518
Number of pages22
JournalCirculation
Volume118
Issue number14
DOIs
StatePublished - Sep 30 2008
Externally publishedYes

Fingerprint

Sudden Cardiac Death
Cardiology
Cardiac Arrhythmias
Electrocardiography
Epidemiology
Mortality
Tachycardia

Keywords

  • AHA Scientific Statements
  • Death, sudden
  • Risk assessment

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death : A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. / Goldberger, Jeffrey J.; Cain, Michael E.; Hohnloser, Stefan H.; Kadish, Alan H.; Knight, Bradley P.; Lauer, Michael S.; Maron, Barry J.; Page, Richard L.; Passman, Rod S.; Siscovick, David; Stevenson, William G.; Zipes, Douglas P.

In: Circulation, Vol. 118, No. 14, 30.09.2008, p. 1497-1518.

Research output: Contribution to journalArticle

Goldberger, Jeffrey J. ; Cain, Michael E. ; Hohnloser, Stefan H. ; Kadish, Alan H. ; Knight, Bradley P. ; Lauer, Michael S. ; Maron, Barry J. ; Page, Richard L. ; Passman, Rod S. ; Siscovick, David ; Stevenson, William G. ; Zipes, Douglas P. / American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death : A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. In: Circulation. 2008 ; Vol. 118, No. 14. pp. 1497-1518.
@article{3830607f86a74e619e095e6ac1caebeb,
title = "American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention",
abstract = "Given the availability of therapies to prevent SCD due to otherwise fatal ventricular tachyarrhythmias, it is important to differentiate noninvasive risk stratification techniques that enhance the ability to identify SCD from total mortality. The relative ability for each of the described techniques varies, and the optimal way to combine and use these techniques in clinical practice remains unclear. Low LVEF, which is the most widely used test on which ICD intervention is recommended, does not have a particularly high discriminatory ability to identify SCD rather than non-SCD mortality. Although data exist supporting the concept that noninvasive risk stratification techniques may be useful to identify patients with low LVEF who are at low risk for SCD, this requires further testing. There are also data to support the concept that noninvasive risk stratification techniques may be useful to identify patients who do not have low LVEF who nevertheless are at substantial risk for SCD. Because most SCD occurs in this latter group, substantial effort is justified in evaluating, testing, and ultimately implementing risk stratification strategies in this group.",
keywords = "AHA Scientific Statements, Death, sudden, Risk assessment",
author = "Goldberger, {Jeffrey J.} and Cain, {Michael E.} and Hohnloser, {Stefan H.} and Kadish, {Alan H.} and Knight, {Bradley P.} and Lauer, {Michael S.} and Maron, {Barry J.} and Page, {Richard L.} and Passman, {Rod S.} and David Siscovick and Stevenson, {William G.} and Zipes, {Douglas P.}",
year = "2008",
month = "9",
day = "30",
doi = "10.1161/CIRCULATIONAHA.107.189375",
language = "English",
volume = "118",
pages = "1497--1518",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "14",

}

TY - JOUR

T1 - American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death

T2 - A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention

AU - Goldberger, Jeffrey J.

AU - Cain, Michael E.

AU - Hohnloser, Stefan H.

AU - Kadish, Alan H.

AU - Knight, Bradley P.

AU - Lauer, Michael S.

AU - Maron, Barry J.

AU - Page, Richard L.

AU - Passman, Rod S.

AU - Siscovick, David

AU - Stevenson, William G.

AU - Zipes, Douglas P.

PY - 2008/9/30

Y1 - 2008/9/30

N2 - Given the availability of therapies to prevent SCD due to otherwise fatal ventricular tachyarrhythmias, it is important to differentiate noninvasive risk stratification techniques that enhance the ability to identify SCD from total mortality. The relative ability for each of the described techniques varies, and the optimal way to combine and use these techniques in clinical practice remains unclear. Low LVEF, which is the most widely used test on which ICD intervention is recommended, does not have a particularly high discriminatory ability to identify SCD rather than non-SCD mortality. Although data exist supporting the concept that noninvasive risk stratification techniques may be useful to identify patients with low LVEF who are at low risk for SCD, this requires further testing. There are also data to support the concept that noninvasive risk stratification techniques may be useful to identify patients who do not have low LVEF who nevertheless are at substantial risk for SCD. Because most SCD occurs in this latter group, substantial effort is justified in evaluating, testing, and ultimately implementing risk stratification strategies in this group.

AB - Given the availability of therapies to prevent SCD due to otherwise fatal ventricular tachyarrhythmias, it is important to differentiate noninvasive risk stratification techniques that enhance the ability to identify SCD from total mortality. The relative ability for each of the described techniques varies, and the optimal way to combine and use these techniques in clinical practice remains unclear. Low LVEF, which is the most widely used test on which ICD intervention is recommended, does not have a particularly high discriminatory ability to identify SCD rather than non-SCD mortality. Although data exist supporting the concept that noninvasive risk stratification techniques may be useful to identify patients with low LVEF who are at low risk for SCD, this requires further testing. There are also data to support the concept that noninvasive risk stratification techniques may be useful to identify patients who do not have low LVEF who nevertheless are at substantial risk for SCD. Because most SCD occurs in this latter group, substantial effort is justified in evaluating, testing, and ultimately implementing risk stratification strategies in this group.

KW - AHA Scientific Statements

KW - Death, sudden

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=54049108914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049108914&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.107.189375

DO - 10.1161/CIRCULATIONAHA.107.189375

M3 - Article

C2 - 18833586

AN - SCOPUS:54049108914

VL - 118

SP - 1497

EP - 1518

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 14

ER -